CBD
1

Leading Edge Appoints Dr. Daniel Holsworth as CSO to Head Up Clinical CBD Research

Leading Edge Pharms appoints Dr. Daniel Holsworth, who has 25 years experience in drug discovery and development, its new Chief Science Officer

CBD
2

Study by Tioga Research Supports Efficacy of Liposomal Compound Silvidiol™

Leading Edge Pharma announced results of a study indicating its proprietary CBD-based pain relief and anti-inflammatory agent Silvidiol™ effectively permeates skin to reach somatic and neuropathic sensory receptors